Reported 0 shares, down 33 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 7000 |
| 2021-12-31 | 17000 |
| 2022-03-31 | 5000 |
| 2022-06-30 | 2000 |
| 2022-09-30 | 2000 |
| 2022-12-31 | 1330 |
| 2023-03-31 | 7112574 |
| 2023-06-30 | 23 |
| 2023-09-30 | 13 |
| 2023-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2023 | Reduced | 0 | -33 (-100.0%) | 0 | $0 | 2024-02-13 | |
| Q3 2023 | Unchanged | 33 | 0 (0.0%) | < 0.01% | $13 | 2023-11-15 | |
| Q2 2023 | Reduced | 33 | -901,434 (-100.0%) | < 0.01% | $23 | 2023-08-14 | |
| Q1 2023 | Added | 901,467 | +899,990 (60933.6%) | < 0.01% | $7,112,574 | 2023-05-15 | |
| Q4 2022 | Added | 1,477 | +7 (0.5%) | < 0.01% | $1,330 | 2023-02-14 | |
| Q3 2022 | Reduced | 1,470 | -3 (-0.2%) | < 0.01% | $2,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 1,473 | -722 (-32.9%) | < 0.01% | $2,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 2,195 | -3,292 (-60.0%) | < 0.01% | $5,000 | 2022-05-13 | |
| Q4 2021 | Added | 5,487 | +3,664 (201.0%) | < 0.01% | $17,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 1,823 | -70 (-3.7%) | < 0.01% | $7,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
23 managers reported BELLEROPHON THERAPEUTICS IN for Q4 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 199,600 | -183,578 | < 0.01% | $6,000 | 3 qtrs |
| RAYMOND JAMES & ASSOCIATES | Unchanged | 10,000 | 0 | < 0.01% | $370 | 3 qtrs |
| CITADEL ADVISORS LLC | Reduced | 0 | -42,717 | 0 | $0 | 2 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 0 | -30,251 | 0 | $0 | 15 qtrs |
| TWO SIGMA ADVISERS LP | Reduced | 0 | -21,500 | 0 | $0 | 3 qtrs |
| MORGAN STANLEY This report | Reduced | 0 | -33 | 0 | $0 | 16 qtrs |
| STATE STREET CORPORATION | Reduced | 0 | -30,127 | 0 | $0 | 15 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Reduced | 0 | -15,313 | 0 | $0 | 2 qtrs |
| GROUP ONE TRADING L P | Reduced | 0 | -2,100 | 0 | $0 | 3 qtrs |
| WELLS FARGO & COMPANY MN | Reduced | 0 | -180,066 | 0 | $0 | 16 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2023
- Filed
- February 13, 2024
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.